| Field | Specification |
|---|---|
| Applications | |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
RNase R is an E. coli exoribonuclease that exhibits 3'-to-5' exonuclease activity, efficiently digesting nearly all linear RNA species. This enzyme does not digest circular, lariat, or double-stranded RNA with short 3’ overhangs (less than seven nucleotides). As such, this enzyme is ideally suited to the study of lariat RNA produced by traditional splicing, as well as circRNAs which arise through back-splicing. By removing linear RNAs from cellular or RNA extracts, RNase R greatly facilitates the identification of circular species through RNA-sequencing. This enables researchers to probe the landscape of splicing events with greater depth.
| Product Component | Quantity |
|---|---|
| RNase R (10 U/µl) | 50 µl |
| 10X RNase R Reaction Buffer | 1.0 ml |
| Specification | Value |
|---|---|
| Enzyme Type | RNase (exoribonuclease) |
| Format | Enzyme Only |
| Exonuclease Activity | 3'→5' exoribonuclease |
| Substrate Selectivity | Degrades linear RNA; spares circular, lariat and dsRNA with 3' overhangs <7 nt |
| Storage Conditions | Store all components at -20 °C. Avoid repeated freeze-thaw cycles of all components to retain maximum performance. All components are stable for 1 year from the date of shipping when stored and handled properly. |
De Tomi E, Orlandi E, Belpinati F, et al. (2024) New axes of interaction in the circ_0079593/miR-516b-5p network in melanoma metastasis cell lines. Genes, 15, 1647. 10.3390/genes15121647
Hu Q, Zhao H, Zhou K, et al. (2025) Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy. Signal Transduction and Targeted Therapy, 10, 411. 10.1038/s41392-025-02512-4
Wesselhoeft RA, Kowalski PS, Parker-Hale FC, et al. (2019) RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Molecular Cell, 74, 508–520.e4. 10.1016/j.molcel.2019.02.015